Clinical Trials Browser

Phase 2 × Thyroid Neoplasms × penpulimab × Clear all

NCT04952493 2022-01-28

Anlotinib or Penpulimab in Combination With RAI for DTC

Phase 2 Unknown

Thyroid Neoplasms